Bupropion as a Smoking Cessation Aid in Alcoholics
Status:
Completed
Trial end date:
2005-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the use of time-released bupropion (Wellbutrin) in
patients receiving treatment for alcohol abuse/dependence as an aid to stop smoking. Patients
will receive either a time-released bupropion or placebo. Both groups will receive nicotine
replacement therapy during the 9 week study. A final followup assessment will be conducted 6
months from the start of treatment.
Phase:
Phase 4
Details
Lead Sponsor:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)